Technological portfolio

IISPV has a wide portfolio of innovative projects in different states of maturity. Here you will find some of our projects for which we seek collaborations with industry and possible licensees.

Highly biocompatible Extracellular vesicles from sustainable sources
+
EMAI: epidemic monitoring based on AI
+
New method for the analysis of non-directed metabolomics data based on LC-MS
+
Methods for the prognosis of hiv-infected subjects
+
Biomarkers of prostate cancer aggressiveness
+
Targeted interventions directed at reducing the levels of circulating succinate in a subject, and kits and method for determining effectiveness of said interventions
+
Succinate as a biomarker for selecting a bariatric surgical procedure and for predicting type 2 diabetes remission after bariatric surgery
+
Diagnosis of non-alcoholic hepatic steatosis
+
Predictive methods of ascending aorta dilation and bicuspid aortic valve
+

About us

Personnel

Research

Training

Actuality

Technological portfolio

Highly biocompatible Extracellular vesicles from sustainable sources

EMAI: epidemic monitoring based on AI

New method for the analysis of non-directed metabolomics data based on LC-MS

Methods for the prognosis of hiv-infected subjects

Biomarkers of prostate cancer aggressiveness

Targeted interventions directed at reducing the levels of circulating succinate in a subject, and kits and method for determining effectiveness of said interventions

Succinate as a biomarker for selecting a bariatric surgical procedure and for predicting type 2 diabetes remission after bariatric surgery

Diagnosis of non-alcoholic hepatic steatosis

Predictive methods of ascending aorta dilation and bicuspid aortic valve

Technological portfolio

Highly biocompatible Extracellular vesicles from sustainable sources

EMAI: epidemic monitoring based on AI

New method for the analysis of non-directed metabolomics data based on LC-MS

Methods for the prognosis of hiv-infected subjects

Biomarkers of prostate cancer aggressiveness

Targeted interventions directed at reducing the levels of circulating succinate in a subject, and kits and method for determining effectiveness of said interventions

Succinate as a biomarker for selecting a bariatric surgical procedure and for predicting type 2 diabetes remission after bariatric surgery

Diagnosis of non-alcoholic hepatic steatosis

Predictive methods of ascending aorta dilation and bicuspid aortic valve

Collaborate with the IISPV and help us improve people's health through research!

We research. We care about your health

Solidarity contributions help us launch research projects that translate into advances and improvements in the diagnosis, prevention and treatment of diseases. Help us advance science and health by making a donation that will be allocated entirely to the line of research of your choice!